Rice Hall James & Associates LLC Sells 22,045 Shares of Amdocs Limited $DOX

Rice Hall James & Associates LLC lowered its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 8.4% during the third quarter, HoldingsChannel reports. The firm owned 239,287 shares of the technology company’s stock after selling 22,045 shares during the quarter. Amdocs comprises 1.1% of Rice Hall James & Associates LLC’s holdings, making the stock its 27th largest holding. Rice Hall James & Associates LLC’s holdings in Amdocs were worth $19,633,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Synovus Financial Corp acquired a new stake in Amdocs during the 1st quarter worth approximately $463,000. Jane Street Group LLC boosted its holdings in shares of Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock valued at $10,608,000 after buying an additional 76,683 shares during the period. WPG Advisers LLC bought a new stake in shares of Amdocs during the first quarter worth $111,000. Magnetar Financial LLC bought a new stake in Amdocs in the 1st quarter valued at $368,000. Finally, Baird Financial Group Inc. boosted its stake in Amdocs by 1.9% in the 1st quarter. Baird Financial Group Inc. now owns 45,052 shares of the technology company’s stock worth $4,122,000 after purchasing an additional 851 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Price Performance

NASDAQ:DOX opened at $81.73 on Friday. The stock has a market capitalization of $8.82 billion, a PE ratio of 16.18, a P/E/G ratio of 1.38 and a beta of 0.43. Amdocs Limited has a 1-year low of $74.32 and a 1-year high of $95.41. The firm has a fifty day simple moving average of $79.82 and a 200 day simple moving average of $84.51. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Wednesday, December 31st. Amdocs’s dividend payout ratio (DPR) is 41.78%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on DOX. Stifel Nicolaus reduced their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, December 20th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Finally, Bank of America decreased their target price on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.00.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.